Clinical Trial

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

Study acronym: OCTOBER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose is to compare median two-year clinical outcome after OCT guided vs. standard guided revascularization of patients requiring complex bifurcation stent implantation
Protocol Amendment History 27 amendments
This ClinicalTrials.gov record has been amended 27 times since 2017-05-30; most recent amendment 2026-05-13.
Status change: Recruiting → Active, Not Recruiting 2023-04-11
Trial Details
NCT Number NCT03171311
Lead Sponsor Aarhus University Hospital Skejby
Collaborators: Abbott
Conditions Ischaemic Heart Disease, Ischemic Heart Disease
Enrollment 1,201 participants
Start Date 2017-07-05
Primary Completion 2022-03-25 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-18